Prenetics Global (PRE) Current Deferred Revenue (2021 - 2025)

Prenetics Global (PRE) has 5 years of Current Deferred Revenue data on file, last reported at $3.1 million in Q4 2025.

• Current Deferred Revenue for Q4 2025 came in at $3.1 million, down 52.46% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.1 million (down 52.46% YoY), and the FY2025 annual result was $3.1 million, down 52.46% from the prior year.
• Current Deferred Revenue eased to $3.1 million in Q4 2025 per PRE's latest filing, from $7.2 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $11.5 million in Q1 2022 and troughed at $3.1 million in Q4 2025.
• A 5-year average of $6.3 million and a median of $5.7 million in 2024 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue plunged 62.06% in 2023, then jumped 47.96% in 2024.
• A 5-year view of Current Deferred Revenue shows it stood at $9.6 million in 2021, then plunged by 40.82% to $5.7 million in 2022, then climbed by 7.7% to $6.1 million in 2023, then increased by 6.22% to $6.5 million in 2024, then plunged by 52.46% to $3.1 million in 2025.
• Business Quant data shows PRE's Current Deferred Revenue at $3.1 million in Q4 2025, $7.2 million in Q3 2025, and $6.6 million in Q2 2025.